Christina M. Dieli-Conwright, PhD, MPH

Using an “Exercise is Medicine” approach, Dr. Dieli-Conwright's research is centered on testing personalized exercise interventions to improve cancer outcomes among individuals across the lifespan diagnosed with cancer.
Rooted in clinical exercise physiology, her research examines mechanisms by which post-diagnosis exercise can impact cancer outcomes with a specific focus on biomarkers related to body composition, inflammation, metabolic dysregulation, and cognition. She derives randomized controlled trials to test whether various types of prescriptive exercise improve cancer outcomes in individuals diagnosed with cancer, across the lifespan from adolescents and young adults to older adults. Additionally, she examines cardiometabolic diseases in minority cancer survivors and utilizes lifestyle interventions to reduce the onset of comorbidities that are more prevalent in minority cancer survivors.
Thus far, her work has largely focused on breast cancer, as Dr. Dieli-Conwright currently leads clinical trials examining the effect of exercise on body composition, adipose tissue inflammation, and cognitive function in breast cancer survivors. She also leads investigations in endometrial, colorectal, prostate, and hematologic cancers. Dr. Dieli-Conwright has a history of funding from the National Cancer Institute, American Cancer Society, American Institute for Cancer Research, and foundation grants.